Robert Lucas, director, quality compliance, regulatory and auditing, Verista, discusses why life sciences leaders must rethink compliance as an integrated, continuously managed discipline to keep pace with evolving regulatory expectations.
The life sciences industry has always operated under close regulatory scrutiny, but the pace and complexity of compliance requirements have accelerated dramatically over the past decade. Driven by rapid technology adoption, globalisation, and increasingly sophisticated regulatory agencies, organisations can no longer afford to treat compliance as a static, box-checking exercise. The landscape is shifting in real time, and the companies best positioned for long-term success are those that recognise this and respond with proactive, programmatic strategies.